Back To TOP

Co-pay Cards Genentech BioOncology™ Co-pay Card

The ZELBORAF Co-pay Card may be able to help with the out-of-pocket costs of your ZELBORAF® (vemurafenib) prescription.

activate card

 


 

Qualified Patients*

  • I am covered by commercial insurance
    • To answer "yes" to this question, you cannot be covered by a government-funded health care program such as Medicare, Medicaid, Medigap, VA, DoD or Tricare
  • I am age 18 years or older
  • I currently live or get treatment in the United States or Puerto Rico

 

If you answered "yes" to all the questions above, you are eligible.

 

* If you are receiving funding from the Genentech® Access to Care Foundation, you are not eligible for the Genentech BioOncology Co-pay Card.
Vermont state laws do not allow programs like this.

 


 

What the card covers

 

 

Need help with enrollment? Call (855) MYCOPAY/(855) 692-6729.

Learn More About
ZELBORAF
  • LEARN about treatment with Zelboraf
  • LEARN HOW the Genentech BioOncology Co-pay Card can help with the out-of-pocket costs for ZELBORAF
  • Form Patient Authorization and Notice of Release of Information

What is ZELBORAF?

ZELBORAF is a prescription medicine used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and has a certain type of abnormal “BRAF” gene.

Your healthcare provider will perform a test to make sure that ZELBORAF is right for you. ZELBORAF is not used to treat melanoma with a normal BRAF gene.

Important Safety Information

ZELBORAF can cause serious side effects, including risk of cancers. ZELBORAF may cause a type of skin cancer called cutaneous squamous cell carcinoma (cuSCC). New melanoma lesions have occurred in people who take ZELBORAF. ZELBORAF may also cause another type of cancer called non-cutaneous squamous cell carcinoma (SCC). Talk with your healthcare provider about your risk for these cancers. Check your skin and tell your doctor about skin changes including a new wart, a sore or bump that bleeds or does not heal, or a mole that changes size or color.

Your healthcare provider should also check for cancers that may not occur on the skin. Tell your healthcare provider about any new symptoms that you get while taking ZELBORAF.

While taking ZELBORAF, you should avoid sunlight. When you go outside, wear clothes that protect your skin, including your head, face, hands, arms, and legs. Use lip balm and a broad-spectrum sunscreen with SPF 30 or higher.

Possible serious side effects of ZELBORAF include severe allergic reactions, severe skin reactions, potentially life-threatening changes in the electrical activity of your heart called QT prolongation, abnormal liver function tests, and eye problems. Tell your doctor if you are pregnant, or plan to become pregnant, as ZELBORAF can harm your unborn baby.

Common side effects of ZELBORAF include joint pain, rash, hair loss, tiredness, sunburn or sun sensitivity, nausea, itching, or warts.

Tell your doctor if you have any side effect that bothers you or does not go away. These are not all of the possible side effects of ZELBORAF. For more information about side effects, ask your doctor or pharmacist.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

Please see accompanying full Prescribing Information and Medication Guide for additional important safety information.